A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Experimental Drug Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to message these accounts privately for supplier links, while also receiving discount codes.
Active Trade on Messaging Platforms
Additionally, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors market the substance there before directing buyers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Experts Express Concerns
However, physicians and chemists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.
Some experts stated the demand for retatrutide could be connected to the increasing cost of approved slimming products such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.
Service Response and Material Removal
According to TikTok, the platform has removed problematic material and banned related hashtags and search suggestions. The organization said it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Online Trading Operations
Investigations also found groups with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays channels with thousands of users, populated with images of slimming results, glowing testimonials and step-by-step instructions for mixing or injecting at home.
Within minutes of joining one group, a vendor shared WhatsApp details, where most purchases occur. The seller provided an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, medical conditions or past usage.
Item Information and Costs
Inside these groups, posts display dark colored parcels with postal service stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how much time a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for the messaging service said it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting substances they can’t verify. Although the science behind this drug is valid, these online products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are using social media. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said.
Her team has previously encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to possibly serious medical dangers”.
